complex
carbohydr
complementari
carbohydratebind
protein
mediat
wide
varieti
physiolog
patholog
import
interact
recent
advanc
carbohydr
chemistri
biochemistri
afford
opportun
develop
bioactiv
complex
carbohydr
per
se
drug
lead
compound
drug
develop
complex
carbohydr
uniqu
among
biopolym
inher
potenti
gener
divers
molecular
structur
protein
vari
linear
sequenc
monom
constitut
individu
monosaccharid
combin
sever
site
carbohydr
ring
linear
branch
array
vari
stereochemistri
linkag
bond
eg
anomer
form
theoret
differ
monosaccarid
link
togeth
gener
distinct
tetrasaccharid
structur
differ
amino
acid
form
distinct
tetrapeptid
sharon
li
oligosaccharid
structur
variat
commonli
occur
via
sulfat
acetyl
phosphoryl
specif
carbohydr
hydroxyl
group
recent
improv
carbohydr
analyt
chemistri
becom
appar
natur
util
versatil
carbohydr
gener
wide
varieti
molecular
structur
unlik
protein
typic
fold
back
form
highli
compact
structur
oligosaccharid
chain
spread
space
carver
brisson
ong
yu
homan
et
al
hydroxyl
group
anion
substitu
present
saccharid
tend
maxim
intermolecular
distanc
exampl
tetrasaccharid
gangliotetraos
fig
molecular
weight
long
dimens
protein
myoglobin
molecular
weight
greater
long
dimens
result
overal
threedimension
structur
oligosaccharid
sensit
subtl
chang
sequenc
linkag
close
relat
tetrasaccharid
pictur
fig
exemplifi
point
similar
carbohydr
sequenc
result
distinct
tertiari
structur
especi
nonreduc
termini
area
glycoconjug
avail
intermolecular
interact
variat
especi
signific
one
consid
hydrogen
bond
oxygen
hydrogen
carbohydr
precis
place
amino
acid
bind
pocket
protein
dictat
bind
specif
quiocho
biolog
evid
see
section
demonstr
divers
carbohydr
structur
use
code
cellular
recognit
regul
complex
carbohydr
mammalian
cell
consist
oligosaccharid
polysaccharid
chain
occur
primarili
conjug
form
glycoprotein
glycolipid
proteoglycan
disproportion
express
glycoconjug
cell
surfac
part
extracellular
matrix
led
hypothesi
function
intercellular
commun
regul
roseman
hakomori
brandley
schnaar
sharon
li
discoveri
carbohydratebind
protein
surfac
mammalian
cell
ashwel
morel
direct
demonstr
specif
complex
carbohydr
structur
modul
import
physiolog
process
confirm
hypothesi
case
biolog
activ
glycoconjug
attribut
oligosaccharid
epitop
consist
specif
arrang
small
number
eight
monosaccharid
concept
epitop
identifi
manufactur
biolog
activ
form
heart
effort
exploit
complex
carbohydr
pharmaceut
articl
address
salient
featur
mammalian
glycoconjug
structur
biosynthesi
present
exampl
biolog
activ
complex
carbohydr
although
would
imposs
review
complex
carbohydr
literatur
comprehens
manner
hope
select
exampl
provid
accur
introduct
pharmacolog
potenti
reader
refer
excel
recent
review
complex
carbohydr
analysi
cum
et
al
tarentino
et
al
lee
varki
biosynthesi
elbein
basu
et
lindahl
et
af
paulson
colley
schachter
brockhausen
schwarzmann
sandhoff
chemic
synthesi
ferrier
paulsen
function
bock
harnett
hakomori
detail
treatment
area
addit
independ
function
oligosaccharid
modifi
activ
protein
coval
attach
mani
glycoprotein
enzym
hormon
requir
glycosyl
express
function
rademach
dwek
ancillari
role
carbohydr
great
import
use
engin
glycoprotein
pharmaceut
address
end
articl
inher
complex
complex
carbohydr
compar
polypeptid
nucleic
acid
impedi
structur
resolut
unambigu
structur
determin
complex
carbohydr
requir
identif
monosaccharid
sequenc
linkag
posit
anomer
configur
hydroxyl
group
modif
improv
saccharid
chromatograph
resolut
detect
kannagi
et
al
lee
mass
spectroscopi
dell
lain
nuclear
magnet
reson
nmr
dabrowski
greatli
enhanc
carbohydr
structur
analysi
biolog
reagent
exoand
endoglycosidas
tarentino
et
ul
carbohydratespecif
antibodi
magnani
carbohydratebind
protein
li
sharon
sharon
li
also
provid
import
tool
determin
carbohydr
structur
novel
techniqu
oligosaccharid
electrophoresi
jackson
lectin
chromatographi
merkl
cum
green
baenzig
smith
torr
promis
make
oligosaccharid
structur
determin
access
individu
investig
analyt
method
improv
explos
discoveri
novel
complex
carbohydr
evidenc
recent
develop
complex
carbohydr
structur
databas
doubet
et
al
current
contain
structur
mammalian
glycoconjug
classifi
glycoprotein
glycolipid
proteoglycan
carri
carbohydr
chain
assembl
primarili
exclus
eight
monosaccharid
shown
fig
monosaccharid
also
found
modifi
form
exampl
human
nacetylneuramin
acid
neuac
fig
also
occur
one
addit
acetyl
group
nglycolyl
deriv
manzi
et
ul
gener
term
sialic
acid
refer
nacyl
deriv
neuramin
acid
form
glucosamin
commonli
found
nacetyl
deriv
glcnac
fig
also
found
nsulfat
deriv
lindahl
et
al
rare
free
amin
thoma
et
al
monosaccharid
modif
essenti
molecular
recognit
case
point
addit
phosphat
ester
termin
mannos
glycoprotein
modif
target
transport
lysosom
kornfeld
see
section
c
glycoconjug
within
particular
class
share
major
structur
featur
often
provid
valid
start
point
structur
analysi
subtl
modif
sequenc
linkag
anomer
configur
hydroxyl
group
modif
lend
specif
requir
biolog
activ
section
major
structur
theme
glycoconjug
class
present
well
common
variat
sinc
sequenc
anomer
configur
linkag
posit
critic
oligosaccharid
threedimension
structur
nomenclatur
devis
briefli
unambigu
express
featur
iupaciub
joint
commiss
biochem
nomenclatur
throughout
articl
shortform
nomenclatur
use
monosaccharid
oligosaccharid
chain
design
abbrevi
fig
follow
anomer
configur
orp
linkag
posit
ring
next
innermost
monosaccharid
chain
exampl
gal
glc
design
galactos
panomer
form
link
glucos
although
explicitli
design
saccharid
articl
pyranos
sixmemb
ring
form
link
via
anomer
carbon
glc
gal
man
fuc
glcnac
galnac
glca
neuac
next
saccharid
chain
branch
indic
parenthes
gal
fuc
glcnac
design
galactos
fucos
link
iposit
glcnac
ring
differ
posit
respect
carbohydr
chain
attach
mammalian
glycoprotein
via
hydroxyl
group
serin
andor
threonin
link
chain
asparagin
nglycosid
link
chain
kornfeld
kornfeld
sharon
li
notabl
except
collagen
carri
galactosid
hydroxylysin
glycoprotein
classifi
rnucin
type
serum
type
base
prototyp
nlink
glycoprotein
respect
classif
becam
obsolet
mani
glycoprotein
found
carri
nlink
chain
polypeptid
kobata
nevertheless
prototyp
nlink
structur
describ
mucin
serum
glycoprotein
remain
basi
subsequ
structur
analys
mucin
larg
highli
glycosyl
protein
major
compon
epitheli
mucos
layer
respiratori
gastrointestin
reproduct
tract
jentoft
polypeptid
human
mucu
glycoprotein
serin
threonin
carri
hundr
short
carbohydr
chain
contrast
one
nlink
chain
typic
found
one
glycoprotein
sinc
nand
carbohydr
chain
differ
basic
structur
biosynthesi
discuss
separ
proteoglycan
serin
threonin
polypeptid
glycosyl
long
chain
repeat
disaccharid
constitut
complex
famili
bioactiv
glycoconjug
treat
separ
class
section
k
c
nlink
glycosyl
mark
branch
man
glcnac
core
pentasaccharid
attach
nglycosid
linkag
asparagin
fig
two
outermost
mannos
core
typic
substitut
addit
mannos
gener
high
mannos
chain
termin
trisaccharid
eg
neuac
gal
glcnac
gener
complex
chain
sinc
core
mannos
glycosyl
multipl
posit
branch
common
branch
structur
either
highmannos
complex
termini
case
one
core
mannos
carri
high
mannos
chain
anoth
carri
complex
chain
gener
hybrid
structur
kobata
although
common
theme
outlin
help
understand
nlink
oligosaccharid
structur
divers
rule
rademach
typic
neuacgal
termini
other
terminu
common
glycoform
human
lh
tsh
hybrid
structur
one
arm
biantennari
branch
terminu
carri
neuacgalglcnacand
green
baenzig
nlink
chain
sometim
quit
larg
termin
repeat
nacetyllactosamin
gal
glcnac
n
group
n
may
chain
neuac
residu
may
number
finn
nlink
carbohydr
chain
ad
grow
protein
translat
endoplasm
reticulum
unlik
glycoconjug
synthes
stepwis
addit
saccharid
activ
nucleotid
sugar
grow
carbohydr
chain
nlink
chain
transfer
tetradecasaccharid
precursor
en
bloc
appropri
asparagin
kornfeld
kornfeld
precursor
branch
glc
man
glcnac
contain
nlink
pentasaccharid
core
attach
via
highenergi
pyrophosph
bond
carrier
lipid
dolichol
tetradecasaccharid
transfer
protein
trim
specif
glucosidas
rnannosidas
elbein
protein
pass
golgi
apparatu
may
modifi
glycosyltransferas
add
termin
sugar
chain
stepwis
fashion
nucleotid
sugar
precursor
shaper
et
af
paulson
colley
schachter
ei
al
oligosaccharid
structur
one
asparagin
vari
particular
polypeptid
site
polypeptid
one
asparagin
glycosyl
particular
cell
type
glycoprotein
synthes
sweidler
et
parekh
et
al
consensu
primari
sequenc
around
glycosyl
asparagin
asnxserthr
kornfeld
kornfeld
howev
minor
sequenc
actual
glycosyl
mechan
polypeptid
sequenc
dictat
oligosaccharid
biosynthesi
determin
carbohydr
chain
attach
mammalian
glycoprotein
serin
threonin
fall
three
major
categori
mucintyp
chain
glcnac
proteoglycan
discuss
section
c
mucintyp
chain
singl
nacetylgalactosamin
galnac
core
saccharid
glycosid
link
ser
thr
fig
gal
neuac
fuc
glcnac
addit
galnac
residu
commonli
found
short
dito
pentasaccharid
linear
branch
chain
although
larg
multibranch
olink
chain
sometim
express
kornfeld
kornfeld
sharon
li
kobata
termin
saccharid
group
mucin
includ
branch
fucosyl
structur
respons
abh
lewi
b
x
blood
group
specif
schachter
brockhausen
olink
carbohydr
attach
protein
primarili
golgi
apparatu
start
transfer
galnac
udpgalnac
directli
serin
threonin
hydroxyl
chain
elong
occur
via
stepwis
addit
monosaccharid
respect
nucleotid
sugar
jentoft
nlink
oligosaccharid
chain
structur
olink
chain
particular
polypeptid
depend
cell
type
glycoprotein
synthes
carlsson
et
ul
recent
monosaccharid
glcn
ac
residu
found
attach
cluster
serin
threonin
cytoplasm
nuclear
protein
torr
hart
glcnac
residu
cell
may
intracellular
oglcnac
potenti
role
molecular
regul
pursu
hart
e
structur
divers
famili
oligosaccharid
occur
cell
surfac
glycosid
attach
lipid
embed
plasma
membran
past
year
wit
explos
interest
molecul
concomit
increas
number
divers
glycolipid
structur
identifi
stult
rt
al
preval
glycolipid
mammalian
tissu
glycosphingolipid
gsl
character
oligosaccharid
chain
oglycosid
link
iposit
hydroxyl
ceramid
cer
lipid
two
long
hydrophob
tail
anchor
gsl
cell
membran
tabl
hakomori
ceramid
contain
longchain
amino
alcohol
sphingosin
fatti
acid
chain
amid
linkag
amin
like
membran
lipid
variat
chain
length
satur
sphingosin
fatti
acid
gener
larg
number
natur
occur
ceramid
structur
signific
yet
unclear
oligosaccharid
chain
gsl
remark
vari
distinct
carbohydr
structur
report
literatur
half
discov
past
decad
found
predominantli
outer
leaflet
plasma
membran
hansson
et
al
express
qualit
quantit
anatom
celltyp
specif
development
regul
pattern
svennerholm
seyfri
er
kracun
rt
yu
et
particular
gsl
identifi
major
antigen
determin
notabl
certain
human
tumor
hakomori
sell
ariga
et
ul
quarl
complex
gsl
structur
foil
attempt
develop
simpl
systemat
nomenclatur
iupaciub
commiss
biochem
nomenclatur
nevertheless
sever
characterist
core
tetrasaccharid
defin
mani
gsl
structur
consid
deriv
andor
truncat
core
structur
shown
fig
tabl
nearli
mammalian
gsl
structur
lactos
group
gal
glc
glycosid
attach
ceramid
notabl
except
galactosylceramid
form
sulfatid
major
glycolipid
brain
elsewher
l
addit
lactos
common
saccharid
found
gsl
gal
galnac
glcnac
neuac
fuc
other
occur
rare
mammal
gsl
oligosaccharid
found
complex
branch
array
long
chain
especi
repeat
gal
glcnac
unit
gsl
contain
one
sialic
acid
residu
classifi
gangliosid
ubiquit
plasma
membran
mammalian
cell
found
much
higher
concentr
neural
tissu
ledeen
yu
saito
gangliosid
gener
consider
excit
potenti
promot
neural
repair
role
neutrophil
cell
adhes
pathogen
receptor
see
section
fucosecontain
gsl
particular
interest
oncofet
antigen
hakomori
blood
group
determin
hakomori
young
inflamm
brandley
et
al
glycosphingolipid
biosynthesi
occur
golgi
apparatu
stepwis
addit
monosaccharid
nucleotid
sugar
grow
chain
separ
glycosyltransferas
respons
addit
type
monosaccharid
linkag
may
transfer
differ
acceptor
differ
site
along
preexist
chain
give
varieti
structur
roseman
basu
et
al
schwarzmann
sandhoff
gsl
express
cell
depend
array
glycosyltransferas
present
factor
control
express
glycosyltransferas
yet
determin
contrast
mammalian
tissu
major
glycolipid
test
sulfogalactosylglycerolipid
glycerol
substitut
hydroxyl
galactosid
fatti
acid
ester
fatti
ether
lposit
unusu
glycolipid
complementari
bind
protein
implic
gamet
recognit
law
et
al
proteoglycan
consist
long
chain
repeat
disaccharid
term
glycosaminoglycan
gag
tabl
ii
classifi
carbohydr
constitu
sulfat
pattern
except
hyaluron
acid
found
attach
core
protein
may
carri
gag
chain
roden
hook
et
al
differ
class
gag
may
coexist
core
protein
may
also
carri
typic
nlink
mucintyp
olink
carbohydr
chain
although
repeat
disaccharid
chain
gag
structur
rudimentari
postpolymer
modif
sulfat
andor
epimer
invers
configur
singl
carbon
atom
make
glycosaminoglycan
among
complex
structur
divers
biopolym
casu
conrad
lindahl
et
af
heparin
wide
administ
complex
carbohydr
drug
case
point
heparin
prepar
consist
highli
heterogen
mixtur
sulfat
glycosaminoglycan
chain
metabol
clip
core
protein
limit
endoglycosidas
cleavag
rang
size
da
lindahl
ef
al
member
heparan
sulfat
class
gag
basic
repeat
disaccharid
heparin
glca
glcnac
postpolymer
enzymat
modif
includ
nsulfat
hexosamin
epimer
glucuron
acid
glca
iduron
acid
idoa
osulf
hydroxyl
idoa
andor
glca
osulf
hydroxyl
hexosamin
sinc
modif
occur
subset
avail
site
uniqu
disaccharid
theoret
gener
although
biosynthet
restrict
limit
number
actual
heparin
disaccharid
lindahl
et
even
thousand
epitop
consist
distinct
hexato
octasaccharid
might
exist
along
heparin
chain
uniqu
potenti
interact
specif
proteinbind
site
explain
wide
rang
biolog
effect
heparin
jaqu
suggest
lockandkey
model
biochemi
none
proven
heparinlheparan
sulfat
glca
glcnr
cal
specif
heparin
view
bag
skeleton
key
fit
mani
lock
detail
structur
one
key
precis
heparin
sequenc
respons
antithrombin
bind
pentasaccharid
elucid
see
section
iii
c
basic
structur
common
modif
gag
present
tabl
gener
consider
appli
class
sulfat
gag
less
structur
divers
found
date
chondroitin
dermatan
keratan
sulfat
heparan
sulfat
heparan
dermatan
chondroitin
sulfat
chain
attach
protein
via
unusu
linkag
tetrasaccharid
glca
gal
gal
xyl
p
ser
xyl
xylos
chain
initi
occur
via
direct
transfer
xyl
udpxyl
serin
hydroxyl
group
core
protein
presum
endoplasm
reticulum
roden
lindahl
pt
ul
addit
two
gal
residu
first
glca
polym
construct
golgi
apparatu
altern
addit
hexosamin
glucuron
acid
residu
nucleotid
sugar
postpolymer
modif
heparan
sulfat
occur
order
fashion
denacetylationnsulf
occur
first
glca
epimer
follow
osulf
remark
postpolymer
modif
occur
within
sec
intrigu
model
explain
find
propos
lindahl
et
al
envis
extend
polysaccharid
chain
travers
fix
array
modifi
enzym
modif
station
immobil
membran
scaffold
model
support
observ
modif
absenc
random
along
heparin
chain
occur
block
unlik
gag
keratan
sulfat
contain
broadli
distribut
nacetyllactosamin
repeat
gal
glcnac
n
found
attach
protein
via
typic
oglycosid
linkag
describ
section
ii
roden
discoveri
complex
carbohydr
bioactiv
kept
pace
rapid
advanc
carbohydr
purif
analysi
synthesi
viral
infect
mammalian
fertil
cellcel
interact
cell
regul
associ
complex
carbohydr
recognit
physiolog
patholog
interact
oligosaccharid
glycoconjug
particip
opportun
pharmacolog
intervent
section
present
exampl
complex
carbohydr
bioactiv
associ
pharmaceut
opportun
mani
pathogen
requir
interact
cellsurfac
complex
carbohydr
essenti
part
etiolog
diseas
caus
among
certain
virus
bacteria
bacteri
exotoxin
complex
carbohydr
pathogen
bind
often
refer
pathogen
receptor
terminolog
confus
one
typic
think
receptor
protein
bind
site
ligand
pathogen
receptor
cell
surfac
ligand
pathogen
protein
bind
paulson
context
receptor
determin
defin
limit
structur
eg
minimum
oligosaccharid
sequenc
recogn
pathogen
sinc
carbohydr
determin
carri
protein
lipid
determin
identifi
experiment
without
determin
glycoconjug
respons
bind
uiuo
determin
may
effect
inhibitor
pathogen
attach
provid
lead
compound
develop
inhibitor
section
summar
welldefin
system
carbohydr
determin
respons
pathogen
bind
protein
exotoxin
releas
bacteria
bind
target
cell
alter
cellular
function
middlebrook
dorland
exotoxin
bind
specif
cellsurfac
complex
carbohydr
one
best
character
carbohydratebind
pathogen
cholera
toxin
protein
exotoxin
vibrio
choleru
respons
sever
diarrhea
cholera
toxin
consist
two
function
subunit
b
aib
heterooligom
holmgren
lonnroth
b
subunit
toxic
bind
avidli
intestin
epitheli
cell
surfac
specif
cellsurfac
gangliosid
gal
galnac
neuac
gal
glc
pi
cer
see
section
b
van
heyningen
b
subunitgml
bind
caus
local
membran
perturb
allow
subunit
travers
membran
enter
cytoplasm
caus
persist
activ
adenyl
cyclas
enzymat
adpribosyl
regulatori
g
protein
cassel
pfeuffer
subunit
dissoci
b
subunit
retain
enzymat
activ
broken
cell
prepar
longer
toxic
intact
cell
cell
lack
g
resist
cholera
toxin
becom
suscept
gangliosid
experiment
insert
plasma
membran
moss
et
al
sinc
cholera
epidemiolog
import
evolutionari
pressur
would
expect
select
express
g
suscept
intestin
epithelium
fact
among
human
tissu
test
intestin
mucosa
lowest
gangliosid
express
svennerholm
persist
express
enough
g
allow
cholera
toxic
may
suggest
essenti
role
gangliosid
intestin
cell
physiolog
although
role
yet
identifi
experiment
studi
test
gangliosid
competit
inhibitor
toxin
human
patient
notabl
treatment
crude
gangliosid
mixtur
actual
worsen
symptom
presum
sinc
administ
gml
spontan
insert
cell
membran
increas
toxin
bind
nalin
contrast
administr
grvzl
preadsorb
charcoal
result
elimin
free
toxin
intestin
lumen
reduc
purg
infect
individu
stoll
e
f
al
unlik
develop
practic
therapi
paradigm
therapeut
applic
complex
carbohydr
identifi
pathogen
receptor
bacteri
exotoxin
appear
util
gangliosid
cellsurfac
receptor
pathogen
esclzerichia
coli
strain
produc
exotoxin
lt
close
relat
cholera
toxin
caus
travel
diarrhea
like
cholera
toxin
lt
bind
gangliosid
g
may
intestin
receptor
holmgren
tsuji
et
ul
anoth
e
colielabor
toxin
verotoxin
bind
neutral
determin
globotriaosylceramid
gal
gal
glc
waddel
er
al
gangliosid
found
vertebr
tissu
predomin
nervou
tissu
surpris
certain
neurotrop
exotoxin
bind
gangliosid
particular
tetanu
botulinum
toxin
block
neurotransmitt
releas
bind
gangliosid
contain
lb
substructur
gal
galnac
neuac
neuac
gal
glc
pl
cer
contain
major
neuron
gangliosid
gtlb
g
habermann
dreyer
montecucco
tetanu
toxin
protein
exotoxin
clostridium
fetani
best
studi
neurotrop
toxin
earli
studi
demonstr
crude
brain
gangliosid
could
fix
tetanu
toxin
uitro
van
heyningen
subsequ
purifi
b
gangliosid
demonstr
select
inhibit
highaffin
tetanu
toxin
bind
isol
brain
membran
suppport
toxin
bind
directli
holmgren
et
al
roger
snyder
critchley
et
ul
tetanu
toxin
molecular
domain
respons
cell
bind
separ
domain
inject
intracellularli
block
exocytosi
penner
et
al
although
molecular
mechan
tetanu
toxic
fulli
resolv
remain
controversi
endogen
receptor
toxin
reason
hypothesi
cellbind
domain
interact
specif
gangliosid
b
famili
lead
uptak
follow
retrograd
transsynapt
transport
subsequ
exocytosisblock
domain
gener
alter
cell
physiolog
block
neurotransmitt
releas
habermann
dreyer
membraneenvelop
virus
surfac
attach
protein
respons
target
cell
bind
best
defin
viral
attach
protein
influenza
virus
paulson
earli
experi
influenza
attach
protein
found
agglutin
red
blood
cell
uitro
lead
term
hemagglutinin
receptordestroy
enzym
found
associ
hemagglutinin
subsequ
identifi
strain
neuraminidas
hemagglutinin
mediat
attach
virus
target
cell
initi
membran
fusion
lead
releas
viral
transcript
complex
cytoplasm
neuraminidas
thought
facilit
subsequ
bud
viru
cell
surfac
discoveri
viral
neuraminidas
receptordestroy
enzym
focus
attent
sialic
acid
viral
receptor
determin
eleg
seri
experi
j
paulson
colleagu
probe
fine
structur
target
cellsurfac
sugar
influenza
virus
bind
higa
et
al
remov
sialic
acid
red
cell
surfac
elimin
viru
bind
resialyl
use
highli
purifi
sialyltransferas
activ
sugar
donor
cmpsialic
acid
reestablish
viru
bind
reveal
subtl
carbohydr
specif
viral
hemagglutinin
viru
isol
requir
neuac
gal
bind
other
requir
neuac
gal
yet
other
bound
either
linkag
isol
requir
sialic
acid
nacetyl
neuac
other
nglycol
neugc
bound
either
structur
even
strain
influenza
c
bound
sialic
acid
acetyl
group
amino
group
hydroxyl
roger
et
al
receptordestroy
enzym
influenza
c
notabl
neuramin
oacetylesteras
bind
select
base
saccharid
fine
structur
demonstr
abil
saccharid
encod
specif
recognit
proteinsaccharid
bind
affin
larg
base
hydrogen
bond
specif
hydroxyl
group
oligosaccharid
precis
posit
amino
acid
residu
bind
pocket
quiocho
subtl
alter
protein
primari
structur
reflect
mark
chang
carbohydr
specif
sinc
primari
threedimension
crystal
structur
influenza
viru
hemagglutinin
known
molecular
detail
carbohydr
recognit
system
access
wei
rt
sinc
glycoprotein
glycolipid
contain
termin
sialic
acid
bind
influenza
viru
uitro
suzuki
et
pritchett
paulson
clear
glycoconjug
respons
infect
uiuo
howev
recent
studi
reveal
addit
key
factor
highaffin
carbohydr
recognit
multival
bind
viral
hemagglutinin
multimer
viral
envelop
bind
avidli
multipl
optim
space
carbohydr
determin
pritchett
paulson
exampl
equin
macroglobulin
highaffin
glycoprotein
receptor
influenza
viru
human
support
lowaffin
bind
surprisingli
oligosaccharid
deriv
glycoprotein
bind
equival
rel
low
affin
evid
space
oligosaccharid
equin
azmacroglobulin
result
optim
bind
hemagglutinin
import
multival
document
detail
proteincarbohydr
bind
system
weigel
et
nl
hardi
rt
lee
lee
schengrund
ringler
import
implic
design
highaffin
carbohydratebas
drug
particular
appropri
space
sialic
acid
residu
synthes
lowmolecularweight
carrier
may
provid
best
opportun
develop
potent
antivir
matrosovich
r
addit
influenza
sever
virus
report
bind
glycoconjug
includ
rabi
viru
sendai
viru
newcastl
diseas
viru
coronavirus
reovirus
holmgren
et
suzuki
rt
superti
et
ul
vlasak
et
ul
willoughbi
et
carbohydr
determin
virus
fulli
character
influenza
unlik
toxin
virus
bacteri
virul
requir
specif
host
cell
bind
per
se
nevertheless
adher
may
protect
bacteria
normal
remov
mechan
fluid
shear
increas
probabl
colon
experiment
evid
suggest
bacteri
lectin
carbohydratebind
protein
function
host
adher
initi
infect
karlsson
ofek
sharon
sugarspecif
adher
bacteria
host
cell
first
detect
abil
enterobacteria
agglutin
red
blood
cell
earli
studi
denot
bacteri
strain
mannos
sensit
agglutin
inhibit
mannos
mannosid
mannos
resist
subsequ
sever
distinct
carbohydr
specif
detect
express
concomitantli
cultur
best
character
these
manspecif
gal
galspecif
bind
pathogen
strain
e
coli
case
lectin
found
tip
filament
bacteri
appendag
term
fimbria
pili
sharon
colleagu
sharon
explor
carbohydr
determin
sever
mannosesensit
bacteri
strain
conclud
e
coli
strain
specif
amannosid
preferenti
bound
natur
occur
structur
contain
nonreduc
termin
man
man
pharmaceut
interest
amannosid
larg
apolar
aglycon
eg
pmethylumbelliferyl
amannosid
potent
natur
occur
oligosaccharid
potent
amethyl
mannosid
inhibit
e
coli
adher
epitheli
cell
investig
demonstr
high
concentr
mannos
mannosid
specif
inhibit
bacteri
infect
number
rodent
experiment
model
ofek
sharon
data
encourag
two
caveat
note
first
bacteria
may
express
multipl
saccharidebind
protein
distinct
determin
specif
second
recognit
mannosid
surfac
macrophag
bacteria
may
actual
facilit
phagocytosi
process
term
lectinoghagocytosi
ofek
sharon
block
defens
mechan
may
counterproduct
experi
determin
effect
carbohydr
inhibitor
antibacteri
form
carbohydratedirect
bacteri
adher
identifi
use
modif
clever
overlay
techniqu
introduc
magnani
et
al
glycolipid
extract
tissu
cell
resolv
thinlay
chromatographi
tlc
subsequ
tlc
plate
dri
plastic
impregn
overlaid
radioact
label
bacteria
hansson
et
al
incub
nonadher
cell
remov
wash
tlc
plate
dri
subject
autoradiographi
glycolipid
bear
receptor
determin
bound
bacteria
bock
et
al
appli
techniqu
uropathogen
strain
e
coli
found
gsl
contain
gal
gal
determin
whether
nonreduc
terminu
intern
oligosaccharid
bound
bacteria
gsl
lack
determin
nonsupport
bind
natur
occur
gsl
contain
determin
appar
extract
human
uret
epithelium
rapid
screen
method
use
detect
bacteri
bind
immobil
gal
gal
e
coli
isol
urin
patient
pyelonephr
isol
normal
fece
posit
bind
enerback
et
al
interest
correl
glycolipid
fine
structur
pathogen
suscept
document
certain
e
cofi
strain
express
antigen
caus
diarrhea
neonat
adult
anim
teneberg
et
al
compon
glycolipid
extract
piglet
intestin
mucosa
bound
bacteria
adult
extract
devoid
bind
activ
receptor
glycolipid
identifi
neugc
gal
glc
pl
cer
gangliosid
nglycolyl
group
sialic
acid
nucetyl
group
sialic
acid
remark
complet
nonsupport
bind
appar
lectin
bacteria
distinguish
presenc
absenc
singl
hydroxyl
group
glycolipid
receptor
da
interest
nglycolyl
form
found
neonat
replac
nacetyl
form
anim
matur
mani
differ
bacteri
speci
strain
bind
lactosylceramid
andor
gangliotetraosylceramid
uifro
karlsson
ofek
sharon
normal
flora
pathogen
strain
variou
tissu
tropism
bind
target
glycolipid
express
mani
differ
tissu
recognit
glycolipid
may
import
colon
physiolog
patholog
signific
bind
yet
establish
among
bacteri
speci
recogn
glycosphingolipid
neisseria
gonorrhoea
respons
one
commonli
report
infecti
diseas
stromberg
et
uf
deal
krivan
use
power
combin
molecular
clone
glycolipid
tlc
overlay
techniqu
paruchuri
e
f
al
directli
isol
recombin
e
coli
harbor
gene
n
gonnorrhoea
surfac
protein
respons
glycolipid
recognit
molecular
character
lectin
provid
tool
establish
function
import
step
toward
develop
carbohydratebas
inhibitor
cellsurfac
glycoconjug
long
posit
act
cellcel
recognit
molecul
sever
possibl
mode
carbohydr
interact
cell
surfac
envis
rosemann
sharon
li
specif
bind
carbohydr
one
cell
protein
receptor
appos
cell
crosslink
surfac
carbohydr
appos
cell
extracellular
solubl
lectin
specif
interact
directli
carbohydr
appos
cell
also
see
eggen
et
al
kojima
hakomori
describ
new
analyt
cell
biolog
techniqu
provid
experiment
evid
demonstr
carbohydratemedi
cellcel
recognit
result
excit
new
opportun
carbohydratebas
drug
develop
hypothesi
cellsurfac
carbohydr
involv
cellcel
recognit
receiv
remark
boost
discoveri
seri
relat
protein
previous
demonstr
mediat
leukocyt
adhes
lectin
immunolog
techniqu
identifi
protein
involv
leukocyt
adhes
vascular
endothelium
stoolman
determin
primari
amino
acid
sequenc
bevilacqua
et
al
johnston
el
laski
et
al
siegelman
et
reveal
three
previous
refer
elaml
contain
structur
motif
relat
wellcharacter
vertebr
lectin
drickam
base
molecular
domain
renam
lecaml
respect
brandley
et
al
previou
data
consist
discoveri
carbohydratebind
domain
lecam
protein
detect
surfac
lymphocyt
respons
bind
special
peripher
lymph
node
vasculatur
term
high
endotheli
venul
jalkanen
et
bind
isol
lymphocyt
lymph
node
tissu
section
potent
inhibit
mannos
phosphat
fucos
sulfat
polym
neuraminidas
sensit
stoolman
et
al
rosen
et
al
signific
data
implic
anion
saccharid
lecam
bind
determin
endogen
structur
respons
bind
elud
character
primarili
difficulti
obtain
suffici
quantiti
high
endotheli
venul
target
tissu
identif
lectin
motif
unexpect
led
investig
search
complementari
carbohydr
ligand
within
month
sever
group
use
varieti
techniqu
independ
identifi
carbohydr
structur
bound
see
report
carbohydratespecif
bind
also
appear
follow
discuss
focus
bind
determin
sinc
intens
scrutini
potenti
carbohydratebas
antiinflammatori
inflamm
involv
specif
bind
leukocyt
activ
endothelium
extravas
surround
tissu
express
human
endotheli
cell
activ
monoclon
antibodi
inhibit
leukocyt
adhes
activ
endotheli
cell
bevilacqua
et
al
discoveri
lectin
domain
bevilacqua
et
al
led
investig
leukocyt
cellsurfac
glycoconjug
respons
leukocyteendotheli
adhes
two
indirect
experiment
approach
prove
inform
transfect
nonmyeloid
cell
cdna
fucosyltransferas
convert
nonbind
binder
among
fucosyl
determin
could
identifi
previous
establish
monoclon
antibodi
bind
correl
best
express
sialyl
lewi
x
sialyl
structur
neuac
gal
fuc
glcnac
low
et
al
cell
adhes
activ
endothelium
inhibit
establish
antisialyl
antibodi
liposom
carri
purifi
glycolipid
sialyl
determin
phillip
et
walz
et
al
similar
result
obtain
tiemey
et
al
use
direct
approach
identifi
endogen
glycoconjug
ligand
glycosphingolipid
extract
neutrophillik
human
myelogen
leukemia
cell
resolv
tlc
plate
place
special
design
cell
adhes
chamber
swankhil
er
al
overlaid
radiolabel
cell
express
adher
cell
detect
autoradiographi
cell
adher
posit
tlc
plate
correspond
migrat
subpopul
glycolipid
support
glycolipid
speci
isol
use
specif
cell
adhes
assay
direct
purif
mass
spectroscopi
carbohydr
composit
linkag
analysi
purifi
glycolipid
reveal
sialyl
determin
relat
structur
neuac
gal
glcnac
gal
fuc
glcnac
concord
report
give
consider
confid
sialyl
relat
structur
form
minimum
bind
determin
provid
excel
lead
compound
drug
develop
significantli
studi
establish
physiolog
import
carbohydratemedi
cell
recognit
demonstr
sever
technolog
rapidli
identifi
relev
carbohydr
determin
first
cellcel
interact
mammalian
develop
specif
bind
complementari
molecul
surfac
sperm
egg
particular
avid
bind
sperm
egg
extracellular
coat
zona
pellucida
requir
penetr
fertil
occur
compel
experiment
evid
identifi
specif
zona
pellucida
glycoprotein
oligosaccharid
determin
target
sperm
bind
wassarman
three
glycoprotein
make
mass
mous
zona
pellucida
respons
specif
sperm
bind
purifi
support
bind
adhes
portion
sperm
head
block
spermegg
associ
uitro
induc
acrosom
reaction
see
glycoprotein
includ
ineffect
sperm
bind
compormis
enzymat
remov
nlink
carbohydr
chain
block
pelimin
remov
olink
carbohydr
chain
portion
sizefraction
olink
oligosaccharid
isol
elimin
inhibit
spermegg
bind
bleil
wassarman
pretreat
oligosaccharid
agalactosidas
sever
glycosidas
includ
pgalactosidas
elimin
inhibitori
activ
treatment
galactos
oxidas
enzym
convert
hydroxyl
galactos
aldehyd
furthermor
agalactos
residu
identifi
immunochem
intact
data
strongli
implic
l
residu
olink
oligosaccharid
part
relev
determin
sperm
bind
success
fertil
requir
sperm
bind
induct
acrosom
reaction
ar
lysosomelik
organel
sperm
head
fuse
plasma
membran
expos
proteas
requir
penetr
purifi
induc
ar
howev
glycopeptid
prepar
although
block
spermegg
bind
glycopeptid
bound
sperm
crosslink
antibodi
ar
proceed
success
treatment
sperm
glycopeptid
monoval
fab
fragment
antibodi
without
effect
howev
crosslink
fab
fragment
intact
antiigg
antibodi
initi
ar
data
suggest
multival
natur
crosslink
spermbind
protein
induc
ar
leyton
sale
observ
sperm
bind
induct
ar
induc
isol
zona
pellucida
glycoprotein
extend
mamalian
speci
includ
man
cross
et
al
structur
detail
spermbind
determin
eagerli
await
may
lead
inform
help
understand
modul
human
fertil
second
proteincarbohydr
interact
bind
sperm
cell
surfac
pgalactosyltransferas
nonreduc
termin
glcnac
residu
egg
surfac
suggest
mediat
spermegg
bind
mous
lopez
et
af
howev
presenc
galactosyltransferas
intact
sperm
membran
remain
controversi
chan
et
unusu
sulfogalactosylglycerolipid
major
testicular
glycolipid
vertebr
see
section
b
promin
testicular
protein
slipi
bind
sulfogalactosylglycerolipid
coloc
glycolipid
earli
spermatogenesi
segreg
prior
sperm
matur
law
et
al
although
also
found
oocyt
may
involv
spermegg
recognit
role
bind
fertil
yet
establish
complex
network
cellcel
interact
vertebr
nervou
system
neuron
connect
topograph
cellular
specif
numer
target
support
cell
among
multipl
system
cell
recognit
oper
nervou
system
promin
divers
cell
surfac
carbohydr
strongli
implic
involv
sensit
analyt
immunochem
techniqu
reveal
cellsurfac
carbohydr
determin
vari
among
distinct
neural
cell
popul
differ
anatom
region
develop
kracun
et
af
regan
et
particularli
fascin
exampl
gangliosid
g
neuac
neuac
gal
glc
pl
cer
evenli
distribut
across
develop
mammalian
retina
structur
group
termin
sialic
acid
distribut
mark
dorsoventr
gradient
may
involv
topograph
recognit
blum
barnstabl
sparrow
barnstabl
exampl
carbohydr
determin
may
involv
neural
recognit
detail
primari
sensori
neuron
dorsal
root
ganglion
receiv
somatosensori
input
peripheri
send
signal
onward
via
project
spinal
cord
sever
distinct
class
dorsal
root
ganglion
neuron
extend
axon
particular
region
lamina
spinal
cord
identifi
anatom
function
criteria
brown
studi
monoclon
anti
bodi
recogn
discret
carbohydr
determin
reveal
distinct
pattern
glycoconjug
express
differ
class
dorsal
root
ganglion
neuron
dodd
jessel
exampl
cell
express
particular
sialyl
globoseri
structur
recogn
antibodi
make
dorsal
root
ganglion
neuron
project
deep
lamina
iv
spinal
cord
target
cell
express
neolactoseri
determin
see
tabl
nonreduc
gal
termini
recogn
antibodi
morpholog
distinct
make
half
dorsal
root
ganglion
neuron
project
superfici
dorsal
spinal
cord
lamina
although
direct
role
glycoconjug
express
system
establish
fascin
correl
distribut
galtermin
determin
galspecif
lectin
report
regan
e
solubl
galspecif
lectin
found
extract
mani
vertebr
tissu
includ
nervou
sytem
barond
locat
intraand
extracellulari
antibodi
galspecif
lectin
reveal
differ
express
subset
dorsal
root
ganglion
neuron
exampl
lectin
design
coloc
cell
project
deeper
lamina
cell
recogn
express
sialyl
globoseri
determin
lectin
found
superfici
dorsal
spinal
cord
asposit
cell
project
deeper
lamina
cell
project
base
correl
propos
extracellular
galspecif
lectin
might
facilit
cellcel
recognit
crosslink
membran
express
appropri
determin
jessel
et
al
b
sulfat
glucuronyl
glycosphingolipid
adhes
determin
patient
plasma
cell
neoplasm
express
monoclon
igm
antibodi
associ
weak
sensori
loss
characterist
peripher
neuropathi
larg
proport
patient
neuropathi
character
disrupt
myelin
membran
schwann
cell
insul
axon
project
central
nervou
system
igm
bind
carbohydr
determin
share
myelin
glycoprotein
glycolipid
also
recogn
mous
monoclon
antibodi
quarl
et
ul
giycosphingolipid
express
determin
purifi
structur
character
chou
e
ariga
et
unusu
nonreduc
termin
saccharid
attach
outermost
gal
neolactosylceramid
core
see
tabl
assum
although
demonstr
similar
structur
carri
immunoreact
glycoprotein
includ
form
wellcharacter
cell
adhes
molecul
schachner
although
hnklreactiv
lipid
found
peripher
axon
schwann
cell
kohriyama
et
al
role
hnki
determin
peripher
nerv
demyelin
remain
specul
rabbit
immun
lipid
carri
determin
show
muscl
weak
sciatic
nerv
damag
kohriyama
et
yu
et
al
plasmapheresi
reduc
neuropathi
patient
express
antibodi
epitop
sherman
et
al
furthermor
determin
may
act
adhes
ligand
cellcel
substratum
adhes
neural
cell
uitro
perturb
hnki
antibodi
hnklreactiv
glycolipid
oligosaccharid
kunemund
et
al
observ
consist
role
hnklreactiv
glycolipid
mainten
peripher
nervou
system
myelin
direct
evid
hn
reactiv
glycosphingolipid
support
schwann
cell
adhes
uitro
recent
report
needham
schnaar
peripher
nerv
glycolipid
resolv
tlc
overlaid
radiolabel
schwann
cell
reactiv
glycosphingolipid
support
cell
adhes
gangliosid
neutral
glycosphingolipid
adhes
cell
type
specif
liver
retina
fibroblast
cell
adher
glycolipid
data
rais
hope
identifi
receptor
molecul
schwann
cell
membran
complementari
determin
might
mediat
cell
recognit
peripher
nervou
system
c
gangliosidebind
protein
central
nervou
system
gangliosid
ubiquit
vertebr
tissu
found
especi
high
concentr
brain
ledeen
much
known
structur
anatom
cellular
distribut
development
express
physiolog
function
remain
elus
recent
discoveri
sialyl
gangliosid
bind
protein
neutrophilendothelium
adhes
see
section
iii
b
strengthen
theori
gangliosid
gangliosidebind
protein
mediat
neural
cell
recognit
complementari
bind
protein
gangliosid
central
nervou
system
recent
probe
use
major
brain
gangliosid
gtlb
neuac
gal
galnac
neuac
neuac
gal
glc
cer
ligand
tiemey
el
coval
link
multipl
gtlb
molecul
via
ceramid
portion
radiolabel
protein
carrier
albumin
highaffin
ligand
gangliosidebind
protein
synthes
radioligand
bind
isol
rat
brain
membran
reveal
highaffin
bind
activ
select
gtlb
relat
structur
subcellular
anatom
studi
local
bind
activ
specif
central
nervou
system
myelin
tiemey
el
structur
much
like
peripher
nervou
system
myelin
elabor
oligodendrogli
cell
rather
schwann
cell
contain
differ
cellsurfac
protein
find
interest
sinc
gtlb
relat
structur
absent
oligodendrogli
membran
domin
speci
axon
ensheath
rais
possibl
myelin
gangliosid
receptor
may
involv
oligodendroglialaxon
recognit
myelin
stabil
noncoval
coval
associ
protein
enzym
intact
cell
specif
complex
carbohydr
act
potent
physiolog
regul
identif
bioactiv
carbohydr
structur
mechan
action
hold
signific
promis
drug
develop
heparin
one
first
carbohydratebas
drug
jaqu
much
known
molecular
structur
mechan
anticoagul
activ
remain
one
complex
function
divers
mixtur
pharmacopeia
jaqu
describ
section
c
postpolymer
modif
result
thousand
epitop
within
glycosaminoglycan
chain
compel
evid
demonstr
biolog
system
take
advantag
subtl
structur
variat
heparin
hold
hope
mani
biolog
effect
trace
specif
defin
oligosaccharid
determin
begin
uncov
medic
relev
substructur
hidden
within
heparin
polym
best
known
effect
heparin
anticoagul
activ
coagul
result
cascad
proteas
activ
anoth
proteas
ultim
thrombin
cleav
fibrinogen
fibrin
crosslink
form
insolubl
clot
reilli
heparin
block
process
sever
step
presenc
anoth
serum
compon
antithrombin
protein
bind
react
sever
clot
factor
includ
thrombin
inactiv
proteas
activ
marcum
er
nl
rate
reaction
thrombin
clot
factor
markedli
enhanc
heparin
bind
directli
free
specif
bind
site
although
heparin
bind
l
complex
atthrombin
heterodim
form
heparin
rapidli
releas
bind
acceler
reaction
second
molecul
thu
act
catalyt
fashion
studi
reveal
carbohydr
determin
heparin
respons
bind
stand
prototyp
elucid
divers
function
heparin
lam
el
al
fraction
whole
heparin
base
abil
bind
purifi
heparin
chain
bound
constitut
approxim
onethird
total
heparin
carri
essenti
anticoagul
activ
random
cleavag
activ
heparin
chain
result
smaller
atbind
oligosaccharid
amen
structur
analysi
chemic
modif
synthet
studi
conjunct
atbind
assay
help
defin
minimum
bind
determin
natur
occur
pentasaccharid
glca
atha
et
al
highaffin
bind
particularli
depend
arrang
osulf
group
remov
either
nonreduc
termin
sulfat
glcnac
center
residu
reduc
atbind
affin
studi
rais
hope
divers
biolog
activ
heparin
identifi
uniqu
small
bind
determin
note
howev
small
determin
saccharid
display
highaffin
bind
enhanc
inhibit
proteas
longer
chain
saccharid
requir
elicit
anticoagul
activ
heparin
choay
suggest
bind
site
larger
complex
bind
studi
indic
multival
ligand
requir
consider
may
complic
potenti
use
synthet
heparin
determin
pharmaceut
heparin
member
famili
heparan
sulfat
broadli
distribut
compon
proteoglycan
found
cell
surfac
extracellular
matrix
well
place
mediat
cell
physiolog
anticoagul
heparan
sulfatecontain
proteoglycan
hspg
demonstr
vascular
endothelium
may
help
protect
surfac
format
thrombi
marcum
et
af
heparin
also
play
role
vascular
smooth
muscl
prolifer
normal
blood
vessel
line
continu
monolay
quiescent
endotheli
cell
cover
medial
layer
quiescent
smooth
muscl
cell
endothelium
remov
experiment
surgic
procedur
pathogen
underli
smooth
muscl
cell
smc
begin
prolifer
perhap
respons
platelet
growth
factor
releas
injur
site
process
lead
patholog
stenosi
austin
et
af
heparin
gag
sharpli
reduc
smc
prolifer
remov
endotheli
layer
uiuo
retard
smc
prolifer
uitro
karnovski
et
id
growth
cell
type
besid
smc
sensit
heparin
heparan
sulfat
although
effect
univers
fedarko
et
al
wright
e
f
ul
endotheli
cell
line
strip
blood
vessel
wall
reestablish
confluent
endotheli
layer
halt
smc
prolifer
castellot
et
uf
test
condit
medium
confluent
endotheli
cell
cultur
smc
growth
inhibit
uifro
found
antiprolif
heparan
sulfat
may
function
normal
vascular
wall
homeostasi
thought
antiprolif
activ
commerci
heparin
due
structur
relat
endogen
endotheli
heparan
sulfat
coagul
atsepharosebind
noncoagul
atnonbind
heparin
fraction
equal
potent
antiprolif
agent
uiuo
uitro
marcum
et
al
karnovski
et
al
structurefunct
studi
type
perform
bind
demonstr
heparin
chain
saccharid
requir
maxim
smc
antiprolif
activ
although
signific
activ
retain
natur
hexasaccharid
synthet
atbind
pentasaccharid
describ
tetraand
disaccharid
devoid
activ
within
size
class
highli
charg
fragment
higher
antiprolif
activ
synthet
oversulf
enhanc
activ
size
class
wright
et
uf
unlik
case
bind
particular
saccharid
residu
set
residu
proven
essenti
smc
antiprolif
activ
heparin
lessen
enthusiasm
isol
highpot
growth
control
determin
heparin
antiprolif
heparin
fragment
devoid
anticoagul
activ
hold
promis
clinic
util
mechan
antiprolif
effect
heparin
unknown
multipl
molecular
site
action
may
exist
three
possibl
mechan
focu
experiment
heparin
heparan
sulfat
may
bind
specif
cell
surfac
receptor
capabl
mediat
neg
growthmodulatori
signal
support
hypothesi
evid
appear
demonstr
heparinbind
protein
uterin
smooth
muscl
lank
et
al
although
antibodi
protein
slow
smc
cell
divis
direct
evid
role
antiprolif
activ
heparin
appear
highaffin
bind
heparin
castellot
et
al
follow
rapid
intern
may
deliv
bioactiv
sequenc
intracellular
site
see
heparin
bind
certain
growth
factor
known
mitogen
smc
present
serum
use
cultur
cell
heparin
bind
growth
factor
may
reduc
mitogen
effect
may
also
stabil
andor
enhanc
action
see
like
heparin
exert
antiprolif
effect
downstream
growth
factor
bind
sinc
cell
prolifer
induc
growth
factor
bind
heparin
phorbol
ester
directli
activ
protein
kinas
c
inhibit
heparin
recent
studi
suggest
heparin
block
protein
kinas
cdepend
pathway
mitogenesi
although
complex
inhibit
suggest
multipl
site
action
wright
et
al
fascin
potenti
mechan
antiprolif
action
heparin
suggest
discoveri
free
heparan
sulfat
chain
nuclei
isol
hepat
cell
nuclear
heparan
chain
could
distinguish
cellular
heparan
base
disaccharid
content
concentr
nuclear
heparan
increas
cell
reach
confluenc
exogen
ad
intact
hspg
isol
radiolabel
confluent
hepatoma
cell
inhibit
cell
growth
logphas
cell
concomitantli
radiolabel
free
heparan
sulfat
chain
appear
nucleu
ishihara
et
al
fedarko
et
al
whether
heparan
sulfat
chain
exist
nuclei
intact
cell
might
modul
nuclear
event
yet
determin
notabl
interact
heparin
growth
factor
involv
acid
basic
form
fibroblast
growth
factor
afgf
bfgf
burgess
maciag
klagsbrun
singlechain
nonglycosyl
polypeptid
share
primari
sequenc
ident
wide
distribut
bodi
mitogen
effect
mediat
highaffin
k
dlo
receptor
found
varieti
cell
type
includ
fibroblast
endotheli
cell
smc
chondrocyt
etc
therapeut
effect
fgf
wound
heal
patholog
made
focu
consider
pharmaceut
interest
editori
remark
high
affin
afgf
bfgf
heparin
use
mean
rapid
isol
heparinsepharos
column
led
classif
heparinbind
growth
factor
burgess
maciag
interact
fgf
heparin
goe
far
beyond
conveni
isol
clearli
impact
physiolog
function
heparin
hspg
potenti
mitogen
activ
afgf
lofold
depend
system
investig
gordon
et
mueller
et
al
although
mechan
potenti
establish
bind
heparin
protect
afgf
bfgf
proteolyt
digest
denatur
mueller
et
al
sommer
rifkin
addit
heparin
may
increas
affin
afgf
receptor
schreiber
et
al
posit
effect
heparin
fgf
activ
thought
due
structur
similar
cellsurfac
hspg
act
endogen
fgf
sink
fgfbind
studi
identifi
endogen
bind
site
high
affin
kdlo
sitescel
low
affin
k
sitescel
fgf
moscatelli
highaffin
site
mediat
signal
transduct
bind
lowaffin
site
block
heparin
destroy
heparinas
hspg
bind
protect
fgf
isol
fgfrespons
cell
saksela
el
al
recent
clever
pan
techniqu
use
isol
cdna
encod
fgfbind
hspg
kiefer
et
af
cell
normal
bind
fgf
stabli
transfect
cdna
express
librari
fgfrespons
cell
subpopul
express
fgfbind
protein
select
adhes
plastic
dish
coat
bfgf
bind
stabli
transfect
cell
line
fgfcoat
plate
block
bfgf
epiderm
growth
factor
egf
heparin
gag
pretreat
cell
heparinas
primari
structur
transfect
cdna
fgfbind
clone
reveal
singl
polypeptid
sever
potenti
gag
glycosyl
site
whether
fgf
bind
uiuo
common
featur
hspg
requir
express
particular
hspg
speci
address
fascin
studi
gordon
er
al
hspg
human
endotheli
cell
cultur
isol
fraction
afgfaffin
column
half
radiolabel
bound
column
half
unretard
bound
hspg
recov
salt
elut
enhanc
mitogen
activ
afgf
endotheli
cell
potenc
heparin
remark
unbound
hspg
potent
inhibit
mitogen
effect
data
rais
possibl
respons
mitogen
could
control
posit
neg
balanc
particular
cellsurfac
hspg
express
half
carbohydr
chain
releas
afgfbind
hspg
elimin
could
rebind
afgf
column
analysi
bind
nonbind
chain
may
reveal
specif
determin
essenti
afgf
bind
determin
would
good
candid
develop
drug
stabil
enhanc
growth
factor
activ
studi
fraction
heparin
fragment
suggest
afgfstimulatori
activ
gener
increas
increas
size
degre
sulfat
sudhalt
et
al
cellsurfac
gangliosid
may
influenc
cell
physiolog
via
two
gener
mechan
hakomori
gangliosid
receptor
one
cell
surfac
may
recogn
bind
gangliosid
second
cell
surfac
tran
configur
eg
section
b
altern
gangliosid
may
interact
later
protein
membran
influenc
activ
ci
configur
latter
mechan
appear
involv
regul
cell
growth
gangliosid
mitogen
respons
cell
egf
significantli
reduc
exogen
addit
gangliosid
neuac
gal
glc
pi
cer
gangliosid
bremer
et
ul
affect
neither
number
affin
egf
receptor
rather
inhibit
receptor
respons
egf
inhibit
hormonedepend
tyrosin
kinas
activ
effect
appear
direct
sinc
purifi
egf
receptor
reconstitut
phospholipid
vesicl
sensit
inhibit
receptor
intact
membran
exogen
ad
may
spontan
incorpor
cell
membran
associ
later
egf
receptor
modul
activ
although
direct
biophys
evid
model
appear
possibl
remain
viabl
observ
neuraminidas
inhibitor
inhibit
catabol
cell
growth
primari
fibroblast
suggest
modul
endogen
level
may
regul
cell
divis
usuki
er
al
notion
support
experi
mutant
cell
line
requir
exogen
ad
galactos
synthes
galcontain
glycoconjug
addit
galactos
essenti
block
respons
cell
egf
although
respons
mitogen
remain
normal
wei
davi
remark
denacetyl
form
discov
small
quantiti
cultur
cell
strong
promot
egfreceptor
kinas
activ
hanai
et
al
togeth
data
support
import
role
gangliosid
ci
regul
growth
hormon
respons
gangliosid
also
report
mediat
cell
differenti
bipot
human
promyelocyt
luekemia
cell
line
induc
differenti
along
either
monocyt
granulocyt
pathway
addit
phorbol
ester
dimethylsulfoxid
respect
collin
monocyt
differenti
result
specif
increas
gangliosid
granulocyt
differenti
accompani
increas
neolactoseri
gangliosid
nojiri
er
al
nojiri
er
al
exogen
addit
gangliosid
induc
differenti
g
g
gener
monocyt
characterist
mixtur
neolactoseri
gangliosid
gener
granulocyt
characterist
mechan
specif
differenti
effect
gangliosid
investig
nakamura
et
al
xia
et
al
gangliosid
found
unusu
high
concentr
membran
neural
cell
much
interest
effect
neuron
differenti
function
mani
effect
gangliosid
nerv
cell
tissu
document
includ
induct
neurit
outgrowth
doherti
et
al
cannella
er
ul
tsuji
et
al
ferreira
el
al
modul
specif
protein
kinas
chan
chan
goldenr
et
al
kreutter
et
al
nagai
tsuji
spare
neuron
injuri
cuello
fact
purifi
gangliosid
prepar
bovin
brain
cronassi
fidia
approv
use
peripher
neuropathi
sever
countri
date
clinic
trial
gangliosid
gener
mix
result
recent
doubleblind
studi
show
littl
therapeut
toxic
effect
high
dose
administ
patient
diabet
neuropathi
amyotroph
later
sclerosi
chronic
neuromuscular
diseas
hallett
er
al
bradley
er
ul
lacomblez
et
ul
million
singl
dose
dispens
letter
distribut
gangliosid
drug
outpac
mechanist
clinic
studi
lead
skeptic
clinic
potenti
editori
nevertheless
compel
bodi
experiment
evid
continu
accumul
suggest
gangliosid
act
neurotroph
neuroregulatori
factor
uitro
uiuo
care
control
studi
elucid
mechan
specif
gangliosid
effect
nervou
system
opportun
exploit
larg
complex
famili
glycoconjug
develop
therapeut
may
aris
intrigu
recent
develop
along
line
discoveri
gangliosid
gangliosid
deriv
spare
neuron
glutamateinduc
toxic
uitro
favaron
et
al
manev
et
ul
find
may
find
clinic
relev
treatment
ischem
brain
injuri
detail
action
gangliosid
nerv
growth
repair
uiuo
v
reader
refer
excel
review
seri
claudio
cuello
whose
care
work
help
refocu
attent
potenti
gangliosid
neurotroph
factor
mani
glycoprotein
oligosaccharid
structur
gener
step
biosynthesi
elucid
specif
function
remain
larg
enigmat
extent
due
inher
complex
elucid
glycosyl
pattern
sever
welldefin
polypeptid
reveal
import
gener
principl
rademach
ef
ul
particular
glycoprotein
often
occur
mani
glycoform
ident
polypeptid
backbon
carri
differ
carbohydr
chain
singl
polypeptid
multipl
carbohydr
chain
usual
distinct
oligosaccharid
structur
glycosyl
site
glycosyl
pattern
microheterogen
random
cell
type
specif
reproduc
given
cell
type
defin
physiolog
experiment
condit
swiedler
et
al
parekh
el
al
result
stabl
famili
glycoform
defin
percent
oligosaccharid
structur
glycosyl
site
differ
cell
type
may
produc
nonoverlap
set
glycoform
presum
differ
glycosyltransferas
express
cell
line
glycosyl
mutat
cell
stabli
transfect
glycosyltransferas
intens
scrutini
factori
glycoform
control
product
stanley
smith
et
al
interest
area
burgeon
sinc
oligosaccharid
alter
modul
intrins
biolog
activ
pharmacodynam
glycoprotein
therapeut
interest
tissu
plasminogen
activ
parekh
er
al
lucor
et
af
erythropoietin
dube
et
al
takeuchi
et
al
biolog
consequ
protein
glycosyl
classifi
biophys
biochem
base
structur
specif
gener
glycosyl
report
stabil
conform
polypeptid
protect
proteolysi
nlink
protein
glycosyl
block
glycoprotein
aggreg
endoplasm
reticulum
degrad
express
function
other
appear
unaffect
olink
glycosyl
physiclli
block
proteas
access
nearbi
peptid
sequenc
cell
mutant
lack
oglycosyl
normal
nglycosyl
certain
plasma
membran
glycoprotein
express
normal
rapidli
degrad
kozarski
et
al
furthermor
oglycosyl
keep
polypeptid
extend
conform
jentoft
especi
relev
larg
da
heavili
oglycosyl
mucin
form
intertangl
network
mucou
membran
physic
protect
pathogen
toxin
import
biochem
consequ
glycosyl
protein
target
intracellular
compart
specif
tissu
mani
lysosom
hydrolas
biosynthet
mark
lysosom
target
phosphoryl
mannos
residu
nlink
oligosaccharid
kornfeld
genet
defect
enzym
respons
phosphat
transfer
result
icel
diseas
hydrolas
miss
lysosom
appear
excess
extracellular
fluid
evid
appropri
mark
lysosom
target
default
pathway
glycoprotein
hydrolas
secret
bind
protein
specif
mannosephosph
residu
respons
transport
relev
hydrolas
lysosom
purifi
ef
al
occur
intracellularli
cell
surfac
may
mediat
manpglycoprotein
endocytosi
particular
import
surviv
serum
glycoprotein
endogen
administ
clearanc
receptor
hepatocyt
macrophag
neufeld
ashwel
field
studi
initi
serendipit
discoveri
et
ul
desialyl
ceruloplasmin
decreas
vivo
serum
half
life
hr
min
eleg
studi
subsequ
identifi
hepatocyt
cellsurfac
galactosebind
protein
respons
rapid
clearanc
ashwel
harford
drickam
et
spiess
biolog
role
hepat
lectin
still
studi
like
exposur
gal
residu
endogen
circul
protein
target
uptak
degrad
liver
lectin
capabl
bind
glycoprotein
via
oligosaccharid
character
mammalian
cell
surfac
includ
reticuloendotheli
cell
receptor
bind
termin
man
glcnac
residu
serum
glycoprotein
haltiwang
hill
stahl
although
endogen
cell
surfac
lectin
confound
therapeut
use
engin
glycoprotein
may
also
use
target
appropri
glycoform
particular
tissu
glycoprotein
oligosaccharid
may
code
specif
cellcel
interact
sialyl
structur
involv
leukocyteendotheli
adhes
see
section
iii
b
found
glycolipid
glycoprotein
fukuda
et
al
epitop
antigen
implic
neural
cell
recognit
see
section
detect
glycolipid
chou
et
al
ariga
et
al
minor
glycoform
known
cell
adhes
molecul
schachner
although
glycoprotein
oligosaccharid
structur
character
ident
oligosaccharid
determin
carri
glycoprotein
glycolipid
may
serv
differ
function
interest
experiment
exampl
report
pacuszka
fishman
artifici
attach
cholera
toxin
receptor
oligosaccharid
gml
see
section
iii
endogen
cellsurfac
protein
although
equival
toxin
bind
cell
surfac
obtain
toxin
unabl
mediat
biochem
chang
deleteri
cell
oligosaccharid
lipid
carrier
introduc
cell
toxin
abl
bind
mediat
biochem
alter
whether
endogen
carbohydr
epitop
share
glycoprotein
glycolipid
mediat
differ
biolog
function
explor
major
advanc
purif
analyt
character
biolog
function
glycoconjug
greatli
broaden
potenti
glycobiolog
therapeut
opportun
unimagin
year
ago
enthusiast
attack
univers
industri
laboratori
glycoprotein
regul
pathogentarget
recognit
neuron
repair
challeng
identifi
specif
carbohydr
structur
gener
biolog
effect
detail
mechan
respons
carbohydratebas
drug
design
develop
lead
compound
alreadi
appar
sever
case
heparin
pentasaccharid
bind
antithrombin
sialyl
glycosid
bind
influenza
viru
sialyl
relat
structur
involv
leukocyteendothelium
adhes
major
remain
hurdl
develop
pharmaceut
includ
design
highaffin
analog
econom
synthesi
improv
select
glycosid
bond
format
chemic
enzymat
via
clone
glycosyltransferas
certainli
play
impon
role
advanc
goal
encourag
recent
discoveri
mani
laboratori
vital
biolog
role
complex
carbohydr
confid
enthusiasm
pharmaceut
applic
high
next
decad
infrastructur
move
carbohydr
research
laboratori
clinic
continu
develop
confid
put
test
